Chilean guidelines for chronic urticaria

被引:0
作者
Aguilera-Insunza, Raquel [1 ]
Correa, Hernan [2 ]
Diaz, Carolina [3 ,4 ]
Angelica Marinovic, Maria [5 ]
Valenzuela, Fernando [6 ,7 ]
机构
[1] Pontificia Univ Catolica Chile, Dept Inmunol Clin & Reumatol, Santiago, Chile
[2] Hosp Dr Sotero del Rio, Serv Dermatol, Santiago, Chile
[3] Clin Las Condes, Unidad Inmunol, Santiago, Chile
[4] Hosp Mil Santiago, Unidad Reumatol & Inmunol, Santiago, Chile
[5] Clin Santa Maria, Unidad Inmunol & Alergias, Santiago, Chile
[6] Univ Chile, Fac Med, Dept Dermatol, Santiago, Chile
[7] Clin Las Condes, Dept Dermatol, Santiago, Chile
关键词
Angioedema; Guideline; Pruritus; Urticaria; QUALITY-OF-LIFE; DOUBLE-BLIND; NONSEDATING ANTIHISTAMINES; DIFFERENTIAL-DIAGNOSIS; H-1-ANTIHISTAMINES; THERAPY; CYCLOSPORINE; VALIDATION; OMALIZUMAB; CLASSIFICATION;
D O I
10.4067/S0034-98872018001101334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic urticaria (CU) is characterized by itchy wheals, angioedema or both lasting six weeks or more. It is classified as spontaneous (CSU) and inducible urticaria (CIndU), depending whether there is an identifiable trigger or not. CSU is the predominant form, affecting more than 75% of patients, although overlaps often occur. The prevalence of CSU throughout life is around 1.8% and predominates in women at a ratio of 2: 1. The higher incidence of CSU is between 20 and 40 years of age and lasts between one to five years. However, in up to 20% of patients the disease may last longer. CSU not only hampers quality of life, but also affect performance at work and school. The diagnosis of CSU is mainly clinical, and laboratory tests are required depending on the clinical history of the patient. Extensive laboratory tests are usually unnecessary. Second generation anti-histamines are used as first line treatment for CSU treatment. In refractory patients, systemic treatments, such as cyclosporine or omalizumab are suggested. We herein report the first Chilean CSU guidelines.
引用
收藏
页码:1334 / 1342
页数:9
相关论文
共 47 条
[1]   A new tool to evaluate the impact of chronic urticaria on quality of life:: chronic urticaria quality of life questionnaire (CU-Q2oL) [J].
Baiardini, I ;
Pasquali, M ;
Braido, F ;
Fumagalli, F ;
Guerra, L ;
Compalati, E ;
Braga, M ;
Lombardi, C ;
Fassio, O ;
Canonica, GW .
ALLERGY, 2005, 60 (08) :1073-1078
[2]   Critical review of generic and dermatology-specific health-related quality of life instruments [J].
Both, Hilde ;
Essink-Bot, Marie-Louise ;
Busschbach, Jan ;
Nijsten, Tamar .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (12) :2726-2739
[3]   EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders [J].
Boyman, O. ;
Kaegi, C. ;
Akdis, M. ;
Bavbek, S. ;
Bossios, A. ;
Chatzipetrou, A. ;
Eiwegger, T. ;
Firinu, D. ;
Harr, T. ;
Knol, E. ;
Matucci, A. ;
Palomares, O. ;
Schmidt-Weber, C. ;
Simon, H-U. ;
Steiner, U. C. ;
Vultaggio, A. ;
Akdis, C. A. ;
Spertini, F. .
ALLERGY, 2015, 70 (07) :727-754
[4]   Pathophysiology of chronic urticaria [J].
Brodell, Lindsey A. ;
Beck, Lisa A. ;
Saini, Sarbjit S. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (04) :291-298
[5]   Differential diagnosis of chronic urticaria [J].
Brodell, Lindsey A. ;
Beck, Lisa A. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (03) :181-188
[6]  
Silvares MRC, 2011, REV ASSOC MED BRAS, V57, P577
[7]   Risk of first-generation H1-antihistamines: a GA2LEN position paper [J].
Church, M. K. ;
Maurer, M. ;
Simons, F. E. R. ;
Bindslev-Jensen, C. ;
van Cauwenberge, P. ;
Bousquet, J. ;
Holgate, S. T. ;
Zuberbier, T. .
ALLERGY, 2010, 65 (04) :459-466
[8]   Role of biologics in intractable urticaria [J].
Cooke, Andrew ;
Bulkhi, Adeeb ;
Casale, Thomas B. .
BIOLOGICS-TARGETS & THERAPY, 2015, 9 :25-33
[9]   Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria [J].
Di Lorenzo, G ;
Pacor, ML ;
Mansueto, P ;
Pellitteri, ME ;
Lo Bianco, C ;
Ditta, V ;
Martinelli, N ;
Rini, GB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :619-625
[10]   Experience with Cyclosporine in Children with Chronic Idiopathic Urticaria [J].
Doshi, Devang R. ;
Weinberger, Miles M. .
PEDIATRIC DERMATOLOGY, 2009, 26 (04) :409-413